A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 267
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CTLs
Long Form : cytotoxic T cells
No. Year Title Co-occurring Abbreviation
2019 Autoimmune pituitary disease: New concepts with clinical implications. ACTH, GH, LCNEC, POMC, PRL, TSH
2019 CTL-Derived Exosomes Enhance the Activation of CTLs Stimulated by Low-Affinity Peptides. GZB, pMHC
2019 Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses. BMDCs, DC
2019 Generation of virus-specific CD8+ T cells by vaccination with inactivated virus in the intestine of ginbuna crucian carp. FI-CHNV
2019 Lenalidomide augments the antitumor activities of Eps8 peptide-specific cytotoxic T lymphocytes against multiple myeloma. Eps8, MM, TAA
2019 Nondestructive, multiplex three-dimensional mapping of immune infiltrates in core needle biopsy. IHC, TILs
2019 On the generation of the MSD-Ѱ class of defective HIV proviruses. ART, MSD
2019 Oxidized carbon nanoparticles as an effective protein antigen delivery system targeting the cell-mediated immune response. BMDMs, IFN-gamma, OCN, OVA
2019 Reduced CTL motility and activity in avascular tumor areas. ---
10  2019 Spatial Lymphocyte Dynamics in Lymph Nodes Predicts the Cytotoxic T Cell Frequency Needed for HIV Infection Control. LNs
11  2019 Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study. GVHD, haplo-HSCT
12  2019 Wiskott-Aldrich syndrome protein may be critical for CD8+ T cell function following MCMV infection. CMV, KO, WAS
13  2018 CD8+ T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress. HBc, HBV, HLA-I, Pc
14  2018 Cellular-based immunotherapy in Epstein-Barr virus induced nasopharyngeal cancer. CBI, DCs, EBV, NK, NPC, TILs
15  2018 Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Lofgren's disease. BAL, LS
16  2018 HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E. pVL
17  2018 Induction and Measurement of Cytotoxic T Lymphocyte Activity. ---
18  2018 Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies. 5-FU, MDSCs, NK, ODE
19  2018 Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine. APCs, MPLA, NP, TLR4
20  2018 Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma. Frax, IFN-gamma, IL-6, NE, TAFs, TGF-beta, Th1, TME
21  2018 Photochemical Treatment of Drosophila APCs Can Eliminate Associated Viruses and Maintain the APC Function for Generating Antigen-Specific CTLs Ex Vivo. APCs
22  2018 Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. CKM, DC, TMEs
23  2018 Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector. TCRs
24  2018 Targeting tumor cells with antibodies enhances anti-tumor immunity. mAb, TTmAb
25  2018 [Enhancement of Cytotoxic T Lymphocytes(CTLs)Infiltration into the Cancer Tissues]. ---
26  2017 A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome. GH, PRL, TSH
27  2017 Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs. PBMCs, PLGA, SwIV
28  2017 CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients. CML, LSCs, TKIs
29  2017 Cytotoxic CD4+ T cells are correlated with better prognosis in Han Chinese grade II and grade III glioma subjects and are suppressed by PD-1 signaling. GzmA, GzmB, PD-1
30  2017 EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. MDSC, PGE2, TME
31  2017 Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy. DC, DLBCL, IFN-DC, MCL, TCL
32  2017 Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells. DCs, iNKT
33  2017 Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8+ Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy. anti-PD-1, GSK, siRNAs, SMIs
34  2017 Imaging Flow Cytometry for Multiparametric Analysis of Molecular Mechanism Involved in the Cytotoxicity of Human CD8+ T-cells. ---
35  2017 Impact of the body mass index on perioperative immunological disturbances in patients with hip and knee arthroplasty. ---
36  2017 Interleukin-18: a regulator of cancer and autoimmune diseases. IFN-gamma, IL, IL-18BP, NK
37  2017 Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). ACs, HCs, IL-21, PBMCs, PMA, PVL
38  2017 Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy. IFN-gamma, JAK, SOCS, STAT
39  2017 The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment. CI, EC, HLA-E, HR, NK, TMAs
40  2017 Transcriptional and epigenetic regulation of T cell hyporesponsiveness. ---
41  2016 Comparison of naive and central memory derived CD8+ effector cell engraftment fitness and function following adoptive transfer. ---
42  2016 Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner. CAR, gB, HCMV, TCR
43  2016 Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice. CIK, DC, ELISA, HCC, LDH
44  2016 Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas. ETBRs, IDH-1, WHO
45  2016 Expression of JAK3 Sensitive Na+ Coupled Glucose Carrier SGLT1 in Activated Cytotoxic T Lymphocytes. JAK3
46  2016 Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism. DC, ELISA, FCS, HBsAg, HBV, mDC, sCD14, TLR4
47  2016 Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release. Arl8, CLL, CTL, LAT
48  2016 Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies. CT
49  2016 MUC1 immunotherapy against a metastatic mammary adenocarcinoma model: Importance of IFN-gamma. MUC1
50  2016 Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs. BMDCs, NP, TB
51  2016 Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity. HDAC, SCA, ZBG
52  2016 T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression. CTLA-4, PR
53  2016 TAP-ing into TIEPPs for cancer immunotherapy. APM, TCR, TEIPP
54  2016 The pro-oxidative drug WF-10 inhibits serial killing by primary human cytotoxic T-cells. ---
55  2016 Transfer of Maternal Immune Cells by Breastfeeding: Maternal Cytotoxic T Lymphocytes Present in Breast Milk Localize in the Peyer's Patches of the Nursed Infant. PPs
56  2016 Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells. HCMV, HDACs, IE, MIEP
57  2016 Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients. DCs, GVL, HSCT, LAAs
58  2015 (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies. DCs, NK, PET
59  2015 Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity. DCs, SLP
60  2015 CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells. APCs, DCs, MPs
61  2015 Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. IKKalpha, IL, PD-L1
62  2015 Malaria and the liver: immunological hide-and-seek or subversion of immunity from within? APCs
63  2015 Perforin expression in plaque psoriasis: an immunohistochemical study. IHC, NK, PASI, PsO
64  2015 Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo. NPs, OVA, OVA-NPs-IL-7
65  2014 A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes. HBc, HBV
66  2014 Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro. CTL, DC, LV-12, LVs, MTT, TAA
67  2014 Antiviral functions of CD8(+) cytotoxic T cells in teleost fish. ---
68  2014 Apoptosis of T-cell subsets in colorectal cancer in vivo. CRC, NK, TILs
69  2014 Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells. AML, AML-DCs, DCs, NF, RIP, TNF
70  2014 Cystatin F regulates proteinase activity in IL-2-activated natural killer cells. CatC, IL-2, NK
71  2014 Exercise effects on polyp burden and immune markers in the ApcMin/+ mouse model of intestinal tumorigenesis. EX, SED
72  2014 Identification of a novel HLA-A 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene. NSCLCs
73  2014 Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer. HSP105, PBMCs, Tgm
74  2014 Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy. CD133-405, CSCs, GBM, HLA
75  2014 Negative and positive separation techniques for the isolation of antigen-specific CD8(+) T cells from blood and tumor tissue. PBMCs, TIL
76  2014 Peptide Vaccines for Hypertension and Diabetes Mellitus. Ang II
77  2014 Therapeutic vaccines for hypertension and dyslipidemia. Ang II
78  2014 Transcriptome profiling of CTLs regulated by rapamycin using RNA-Seq. mTOR
79  2014 Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. ATL, HT-9, HTLV-1, TCR
80  2014 Vaccination strategies to improve outcome of hematopoietic stem cell transplant in leukemia patients: early evidence and future prospects. HSCT
81  2013 Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses invitro. GVHD, GVL, HLA
82  2013 Dendritic cell-based immunotherapy for myeloid leukemias. DCs, LSCs, MRD
83  2013 Direct antibacterial activity of CD8+/CD4+ T-cells in ginbuna crucian carp, Carassius auratus langsdorfii. ---
84  2013 Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity. RT
85  2013 Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer. ---
86  2013 IL-27 in tumor immunity and immunotherapy. APCs, DCs, IL, NK
87  2013 Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine. ID
88  2013 Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. CHB, HCC, LC
89  2013 Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity. rhIL-2
90  2013 Pharmacotherapy versus T lymphocytes for CMV. CMV, HSCT
91  2013 Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases. EBV, HLH, NK, PIDs
92  2013 Processing and regulation mechanisms within antigen presenting cells: a possibility for therapeutic modulation. APCs, MHC-I, Ths
93  2013 Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells. CMV, ELISPOT, HSCT, RT-PCR
94  2013 The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131. hNIS, LDH
95  2013 The role of mannose-6-phosphate receptor and autophagy in influencing the outcome of combination therapy. IGF2R
96  2012 Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill beta-cells. PPI
97  2012 Cross-immunizing potential of tumor MAGE-A epitopes recognized by HLA-A*02:01-restricted cytotoxic T lymphocytes. ---
98  2012 Expression of chondroitin-glucuronate C5-epimerase and cellular immune responses in patients with hepatocellular carcinoma. AFP, ELISPOT, HCC, PBMCs
99  2012 High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. moDCs
100  2012 Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. DFS, HCC, OS, TILs